The association of CTLA-4 A49G polymorphism with colorectal cancer risk in a Chinese Han population

Int J Immunogenet. 2015 Apr;42(2):93-9. doi: 10.1111/iji.12181. Epub 2015 Feb 16.

Abstract

Cytotoxic T-lymphocyte antigen-4 (CTLA-4) is expressed in T cells and plays an important role in the regulation of T cell. CTLA-4 has long been considered to be associated with various kinds of diseases. With the attempt to examine the association between CTLA-4 A49G polymorphism and colorectal cancer risk in a Chinese Han population, we employed TaqMan assay to genotype the CTLA-4 A49G polymorphism in 311 colorectal cancer cases and 389 cancer-free controls. We found evidence of the association between CTLA-4 A49G polymorphism and colorectal cancer risk (GG vs. AA: OR = 2.01, 95% CI = 1.29-3.07, P = 0.002; GA vs. AA: OR = 2.32, 95% CI = 1.53-3.57, P = 0.001; GA + GG vs. AA: OR = 2.16, 95% CI = 1.46-3.21, P = 0.001). Next, we performed a meta-analysis to comprehensively examine the association between CTLA-4 A49G polymorphism and colorectal cancer risk. We found a significant association between CTLA-4 A49G polymorphism and colorectal cancer risk among Asians, which is consistent with our result. However, we found no evidence for the association between CTLA-4 A49G polymorphism and colorectal cancer risk among Caucasians. In conclusion, we demonstrated that the CTLA-4 A49G polymorphism increased the susceptibility of colorectal cancer in Asian population.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alleles
  • CTLA-4 Antigen / genetics*
  • Case-Control Studies
  • China
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / pathology
  • Female
  • Genetic Association Studies*
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Odds Ratio
  • Polymorphism, Genetic*
  • Polymorphism, Single Nucleotide
  • Risk Factors

Substances

  • CTLA-4 Antigen